Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

RDGT vs WGRX vs HSIC vs OMI

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
RDGT
Ridgetech Inc.

Medical - Distribution

HealthcareNASDAQ • CN
Market Cap$382.00
5Y Perf.-99.4%
WGRX
Wellgistics Health, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8M
5Y Perf.-96.7%
HSIC
Henry Schein, Inc.

Medical - Distribution

HealthcareNASDAQ • US
Market Cap$8.09B
5Y Perf.-2.3%
OMI
Owens & Minor, Inc.

Medical - Distribution

HealthcareNYSE • US
Market Cap$171M
5Y Perf.-76.9%

RDGT vs WGRX vs HSIC vs OMI — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
RDGT logoRDGT
WGRX logoWGRX
HSIC logoHSIC
OMI logoOMI
IndustryMedical - DistributionMedical - DistributionMedical - DistributionMedical - Distribution
Market Cap$382.00$8M$8.09B$171M
Revenue (TTM)$259M$6M$13.18B$2.76B
Net Income (TTM)$7M$-73M$398M$-1.10B
Gross Margin8.3%4.1%29.1%
Operating Margin-1.8%-12.1%5.8%1.0%
Forward P/E13.3x2.3x
Total Debt$10M$25M$3.69B$320M
Cash & Equiv.$13M$1M$156M$282M

RDGT vs WGRX vs HSIC vs OMILong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

RDGT
WGRX
HSIC
OMI
StockFeb 25May 26Return
Ridgetech Inc. (RDGT)1000.6-99.4%
Wellgistics Health,… (WGRX)1003.3-96.7%
Henry Schein, Inc. (HSIC)10097.7-2.3%
Owens & Minor, Inc. (OMI)10023.1-76.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: RDGT vs WGRX vs HSIC vs OMI

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: HSIC leads in 4 of 7 categories, making it the strongest pick for growth and revenue expansion and profitability and margin quality. Ridgetech Inc. is the stronger pick specifically for operational efficiency and capital deployment. OMI also leads in specific categories worth noting. As sector peers, any of these can serve as alternatives in the same allocation.
RDGT
Ridgetech Inc.
The Niche Pick

RDGT is the #2 pick in this set and the best alternative if efficiency is your priority.

  • 8.7% ROA vs WGRX's -138.4%, ROIC -2.4% vs -32.2%
Best for: efficiency
WGRX
Wellgistics Health, Inc.
The Secondary Option

WGRX lags the leaders in this set but could rank higher in a more targeted comparison.

Best for: healthcare exposure
HSIC
Henry Schein, Inc.
The Income Pick

HSIC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.

  • Dividend streak 1 yrs, beta 0.73
  • Rev growth 4.0%, EPS growth 7.2%, 3Y rev CAGR 1.4%
  • 5.3% 10Y total return vs OMI's -86.2%
  • Lower volatility, beta 0.73, Low D/E 76.9%, current ratio 1.38x
Best for: income & stability and growth exposure
OMI
Owens & Minor, Inc.
The Value Play

OMI is the clearest fit if your priority is value.

  • Lower P/E (2.3x vs 13.3x)
Best for: value
See the full category breakdown
CategoryWinnerWhy
GrowthHSIC logoHSIC4.0% revenue growth vs WGRX's -91.8%
ValueOMI logoOMILower P/E (2.3x vs 13.3x)
Quality / MarginsHSIC logoHSIC3.0% margin vs WGRX's -13.0%
Stability / SafetyHSIC logoHSICBeta 0.73 vs OMI's 1.44
DividendsTieNone of these 4 stocks pay a meaningful dividend
Momentum (1Y)HSIC logoHSIC+5.9% vs RDGT's -99.1%
Efficiency (ROA)RDGT logoRDGT8.7% ROA vs WGRX's -138.4%, ROIC -2.4% vs -32.2%

RDGT vs WGRX vs HSIC vs OMI — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

RDGTRidgetech Inc.

Segment breakdown not available.

WGRXWellgistics Health, Inc.
FY 2024
Product
100.0%$18M
HSICHenry Schein, Inc.
FY 2018
Healthcare Distribution
96.1%$12.7B
Technology
3.9%$509M
OMIOwens & Minor, Inc.
FY 2025
Diabetes Product
56.9%$783M
Product and Service, Other
20.9%$288M
Wound Care
13.7%$189M
Urology
8.4%$116M

RDGT vs WGRX vs HSIC vs OMI — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLHSICLAGGINGOMI

Income & Cash Flow (Last 12 Months)

HSIC leads this category, winning 5 of 6 comparable metrics.

HSIC is the larger business by revenue, generating $13.2B annually — 2346.3x WGRX's $6M. HSIC is the more profitable business, keeping 3.0% of every revenue dollar as net income compared to WGRX's -13.0%. On growth, HSIC holds the edge at +7.7% YoY revenue growth, suggesting stronger near-term business momentum.

MetricRDGT logoRDGTRidgetech Inc.WGRX logoWGRXWellgistics Healt…HSIC logoHSICHenry Schein, Inc.OMI logoOMIOwens & Minor, In…
RevenueTrailing 12 months$259M$6M$13.2B$2.8B
EBITDAEarnings before interest/tax$2M-$65M$1.1B$277M
Net IncomeAfter-tax profit$7M-$73M$398M-$1.1B
Free Cash FlowCash after capex-$10M-$7M$561M-$353M
Gross MarginGross profit ÷ Revenue+8.3%+4.1%+29.1%
Operating MarginEBIT ÷ Revenue-1.8%-12.1%+5.8%+1.0%
Net MarginNet income ÷ Revenue+2.6%-13.0%+3.0%-39.8%
FCF MarginFCF ÷ Revenue-3.7%-130.5%+4.3%-12.8%
Rev. Growth (YoY)Latest quarter vs prior year-11.7%-80.9%+7.7%-146.3%
EPS Growth (YoY)Latest quarter vs prior year+97.5%-11.8%+14.9%+4.5%
HSIC leads this category, winning 5 of 6 comparable metrics.

Valuation Metrics

RDGT leads this category, winning 4 of 6 comparable metrics.

On an enterprise value basis, OMI's 1.7x EV/EBITDA is more attractive than HSIC's 10.9x.

MetricRDGT logoRDGTRidgetech Inc.WGRX logoWGRXWellgistics Healt…HSIC logoHSICHenry Schein, Inc.OMI logoOMIOwens & Minor, In…
Market CapShares × price$382$8M$8.1B$171M
Enterprise ValueMkt cap + debt − cash-$2M$32M$11.6B$209M
Trailing P/EPrice ÷ TTM EPS0.00x-0.68x21.56x-0.16x
Forward P/EPrice ÷ next-FY EPS est.13.26x2.31x
PEG RatioP/E ÷ EPS growth rate6.84x
EV / EBITDAEnterprise value multiple-0.48x10.87x1.70x
Price / SalesMarket cap ÷ Revenue0.00x0.44x0.61x0.06x
Price / BookPrice ÷ Book value/share0.00x0.68x1.79x
Price / FCFMarket cap ÷ FCF0.00x14.12x
RDGT leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

RDGT leads this category, winning 6 of 9 comparable metrics.

RDGT delivers a 29.1% return on equity — every $100 of shareholder capital generates $29 in annual profit, vs $-21 for OMI. RDGT carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to WGRX's 3.73x. On the Piotroski fundamental quality scale (0–9), RDGT scores 6/9 vs OMI's 2/9, reflecting solid financial health.

MetricRDGT logoRDGTRidgetech Inc.WGRX logoWGRXWellgistics Healt…HSIC logoHSICHenry Schein, Inc.OMI logoOMIOwens & Minor, In…
ROE (TTM)Return on equity+29.1%-10.8%+8.2%-21.1%
ROA (TTM)Return on assets+8.7%-138.4%+3.6%-44.9%
ROICReturn on invested capital-2.4%-32.2%+7.1%+1.8%
ROCEReturn on capital employed-4.1%-73.4%+9.8%+1.3%
Piotroski ScoreFundamental quality 0–96642
Debt / EquityFinancial leverage0.35x3.73x0.77x
Net DebtTotal debt minus cash-$2M$24M$3.5B$38M
Cash & Equiv.Liquid assets$13M$1M$156M$282M
Total DebtShort + long-term debt$10M$25M$3.7B$320M
Interest CoverageEBIT ÷ Interest expense-10.95x4.59x-0.12x
RDGT leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

HSIC leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in HSIC five years ago would be worth $8,746 today (with dividends reinvested), compared to $0 for RDGT. Over the past 12 months, HSIC leads with a +5.9% total return vs RDGT's -99.1%. The 3-year compound annual growth rate (CAGR) favors HSIC at -4.0% vs RDGT's -91.6% — a key indicator of consistent wealth creation.

MetricRDGT logoRDGTRidgetech Inc.WGRX logoWGRXWellgistics Healt…HSIC logoHSICHenry Schein, Inc.OMI logoOMIOwens & Minor, In…
YTD ReturnYear-to-date-99.6%-79.7%-8.2%-3.4%
1-Year ReturnPast 12 months-99.1%-98.0%+5.9%-71.1%
3-Year ReturnCumulative with dividends-99.9%-97.7%-11.7%-87.4%
5-Year ReturnCumulative with dividends-100.0%-97.7%-12.5%-93.5%
10-Year ReturnCumulative with dividends-100.0%-97.7%+5.3%-86.2%
CAGR (3Y)Annualised 3-year return-91.6%-71.5%-4.0%-49.9%
HSIC leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

HSIC leads this category, winning 2 of 2 comparable metrics.

HSIC is the less volatile stock with a 0.73 beta — it tends to amplify market swings less than OMI's 1.44 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HSIC currently trades 79.0% from its 52-week high vs RDGT's 0.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricRDGT logoRDGTRidgetech Inc.WGRX logoWGRXWellgistics Healt…HSIC logoHSICHenry Schein, Inc.OMI logoOMIOwens & Minor, In…
Beta (5Y)Sensitivity to S&P 5001.10x0.96x0.73x1.44x
52-Week HighHighest price in past year$760.50$7.04$89.29$9.55
52-Week LowLowest price in past year$1.23$0.08$61.95$1.84
% of 52W HighCurrent price vs 52-week peak+0.2%+1.3%+79.0%+23.5%
RSI (14)Momentum oscillator 0–10032.831.239.146.5
Avg Volume (50D)Average daily shares traded59.4M13.8M1.2M690K
HSIC leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

HSIC leads this category, winning 1 of 1 comparable metric.

Analyst consensus: HSIC as "Hold", OMI as "Hold". Consensus price targets imply 78.6% upside for OMI (target: $4) vs 22.6% for HSIC (target: $86).

MetricRDGT logoRDGTRidgetech Inc.WGRX logoWGRXWellgistics Healt…HSIC logoHSICHenry Schein, Inc.OMI logoOMIOwens & Minor, In…
Analyst RatingConsensus buy/hold/sellHoldHold
Price TargetConsensus 12-month target$86.43$4.00
# AnalystsCovering analysts3210
Dividend YieldAnnual dividend ÷ price
Dividend StreakConsecutive years of raises10
Dividend / ShareAnnual DPS
Buyback YieldShare repurchases ÷ mkt cap0.0%0.0%+10.5%0.0%
HSIC leads this category, winning 1 of 1 comparable metric.
Key Takeaway

HSIC leads in 4 of 6 categories (Income & Cash Flow, Total Returns). RDGT leads in 2 (Valuation Metrics, Profitability & Efficiency).

Best OverallHenry Schein, Inc. (HSIC)Leads 4 of 6 categories
Loading custom metrics...

RDGT vs WGRX vs HSIC vs OMI: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is RDGT or WGRX or HSIC or OMI a better buy right now?

For growth investors, Henry Schein, Inc.

(HSIC) is the stronger pick with 4. 0% revenue growth year-over-year, versus -74. 2% for Owens & Minor, Inc. (OMI). Henry Schein, Inc. (HSIC) offers the better valuation at 21. 6x trailing P/E (13. 3x forward), making it the more compelling value choice. Analysts rate Henry Schein, Inc. (HSIC) a "Hold" — based on 32 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — RDGT or WGRX or HSIC or OMI?

On forward P/E, Owens & Minor, Inc.

is actually cheaper at 2. 3x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — RDGT or WGRX or HSIC or OMI?

Over the past 5 years, Henry Schein, Inc.

(HSIC) delivered a total return of -12. 5%, compared to -100. 0% for Ridgetech Inc. (RDGT). Over 10 years, the gap is even starker: HSIC returned +5. 3% versus RDGT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — RDGT or WGRX or HSIC or OMI?

By beta (market sensitivity over 5 years), Henry Schein, Inc.

(HSIC) is the lower-risk stock at 0. 73β versus Owens & Minor, Inc. 's 1. 44β — meaning OMI is approximately 97% more volatile than HSIC relative to the S&P 500. On balance sheet safety, Ridgetech Inc. (RDGT) carries a lower debt/equity ratio of 35% versus 4% for Wellgistics Health, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — RDGT or WGRX or HSIC or OMI?

By revenue growth (latest reported year), Henry Schein, Inc.

(HSIC) is pulling ahead at 4. 0% versus -74. 2% for Owens & Minor, Inc. (OMI). On earnings-per-share growth, the picture is similar: Ridgetech Inc. grew EPS 162. 8% year-over-year, compared to -201. 1% for Owens & Minor, Inc.. Over a 3-year CAGR, HSIC leads at 1. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — RDGT or WGRX or HSIC or OMI?

Ridgetech Inc.

(RDGT) is the more profitable company, earning 8. 5% net margin versus -39. 8% for Owens & Minor, Inc. — meaning it keeps 8. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: HSIC leads at 5. 7% versus -33. 9% for WGRX. At the gross margin level — before operating expenses — HSIC leads at 29. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is RDGT or WGRX or HSIC or OMI more undervalued right now?

On forward earnings alone, Owens & Minor, Inc.

(OMI) trades at 2. 3x forward P/E versus 13. 3x for Henry Schein, Inc. — 11. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OMI: 78. 6% to $4. 00.

08

Which pays a better dividend — RDGT or WGRX or HSIC or OMI?

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

09

Is RDGT or WGRX or HSIC or OMI better for a retirement portfolio?

For long-horizon retirement investors, Henry Schein, Inc.

(HSIC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 73)). Both have compounded well over 10 years (HSIC: +5. 3%, OMI: -86. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between RDGT and WGRX and HSIC and OMI?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

RDGT

Quality Business

  • Sector: Healthcare
  • Market Cap > $500M
Run This Screen
Stocks Like

WGRX

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Stocks Like

HSIC

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 17%
Run This Screen
Stocks Like

OMI

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform RDGT and WGRX and HSIC and OMI on the metrics below

Revenue Growth>
%
(RDGT: -11.7% · WGRX: -80.9%)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.